行情

EXAS

EXAS

精密科学
NASDAQ

实时行情|Nasdaq Last Sale

74.03
-2.00
-2.63%
盘后: 74.00 -0.03 -0.04% 19:49 01/21 EST
开盘
75.08
昨收
76.03
最高
78.24
最低
74.00
成交量
303.02万
成交额
--
52周最高
159.54
52周最低
69.75
市值
128.57亿
市盈率(TTM)
-14.8717
分时
5日
1月
3月
1年
5年
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Benzinga · 2天前
Exact Sciences 宣布提高第二代 Cologuard 测试的准确性
Exact Sciences (NASDAQ:EXAS) announces improved accuracy of its second-generation Cologuard test, a non-invasive stool DNA test used to screen people for colorectal cancer (NYSE:CRC). The test showed overall sensitivity of 95.2%
Seekingalpha · 4天前
BRIEF-Exact Sciences Announces Performance Data For Second-Generation Cologuard Test
reuters.com · 4天前
Exact Sciences Presents Data On Accuracy Of Second-Generation Cologuard Test, Progress Toward An Even Better Colorectal Cancer Screening Solution For Patients
Exact Sciences Corp. (NASDAQ:EXAS) today announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing overall sensitivity of 95.2% for colorectal cancer (CRC) at
Benzinga · 4天前
Exact Sciences Presents Data Showing Improved Accuracy of Second-generation Cologuard® Test and Progress Toward an Even Better Colorectal Cancer Screening Solution for Patients
Exact Sciences Corp. (NASDAQ: EXAS) today announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing overall sensitivity of 95.2% for colorectal cancer (CRC) at specificity of 92.4% for negative samples confirmed by ...
PR Newswire · 4天前
CHICAGO TRUST Co NA Buys Mastercard Inc, The Home Depot Inc, Boston Scientific Corp, Sells ...
Investment company CHICAGO TRUST Co NA (Current Portfolio) buys Mastercard Inc, The Home Depot Inc, Boston Scientific Corp, Keysight Technologies Inc, Exact Sciences Corp, sells Wintrust Financial Corp, Biogen Inc, Activision Blizzard Inc, Boeing Co, Telad...
GuruFocus.com · 4天前
Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years?
One of the best-known and well-covered ETF companies over the past five years has been ARK Invest, led by Cathie Wood. With the funds falling over the past year and hitting new lows, Benzinga asked which fund would be favored to buy and hold.
Benzinga · 01/14 21:32
Why Exact Sciences Share Are Falling Today?
Exact Sciences Corp (NASDAQ: EXAS) has put down 
Benzinga · 01/10 17:42
更多
财务预测
实际值（美元）
预测值（美元）
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解EXAS最新的财务预测，通过EXAS每股收益，每股净资产，每股现金流等数据分析精密科学近期的经营情况，然后做出明智的投资选择。
分析师评级

19位分析师的综合评级

买入

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

47.37%强力推荐
42.11%买入
10.53%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测EXAS价格均价为129.88，最高价位161.00，最低价为95.00。
最高161.00
均价129.88
最低95.00
现价74.03
EPS
实际EPS
预期EPS
-2.23-1.67-1.12-0.56
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 817
机构持股: 1.76亿
持股比例: 101.59%
总股本: 1.74亿
类型机构数股数
增持
238
1,225.57万
建仓
52
47.33万
减持
168
775.66万
平仓
68
117.06万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-1.82%
制药与医学研究
-1.11%
高管信息
Chairman/President/Chief Executive Officer/Director
Kevin Conroy
Chief Financial Officer/Chief Operating Officer/Executive Vice President
Jeffrey Elliott
Senior Vice President/Chief Administrative Officer/General Counsel/Secretary
D. Scott Coward
Senior Vice President
Ana Hooker
Chief Scientific Officer
Graham Lidgard
General Manager
Jake Orville
General Manager
Gisela Paulsen
Independent Director
James Doyle
Independent Director
Pierre Jacquet
Independent Director
Daniel Levangie
Independent Director
Freda Lewis-Hall
Independent Director
Shacey Petrovic
Independent Director
Kathleen Sebelius
Independent Director
Katherine Zanotti
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
EXAS 简况
Exact Sciences Corporation是一家癌症筛查和诊断公司。该公司专注于早期检测和预防某些类型的癌症。该公司提供了一种称为Cologuard的非侵入性筛查测试，可用于大肠癌、癌前期和Oncotype DX的早期检测。Cologuard测试是一种基于粪便的脱氧核糖核酸（sDNA）筛选测试，利用多目标方法来检测与大肠癌和癌前期相关的脱氧核糖核酸（DNA）和血红蛋白生物标志物。Cologuard测试旨在定性检测结直肠瘤形成相关的DNA标记，并检测人类粪便中是否存在隐匿性血红蛋白。该公司专注于开发其他类型癌症的附加测试，该公司正在开发一种基于血液的生物标志物测试，通过计算机断层扫描（CT）或其他扫描发现的患有肺结节的个体来协助肺癌早期诊断。

微牛提供EXACT Sciences Corporation(NASDAQ-EXAS)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的EXAS股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易EXAS股票基本功能。